Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, T-Cell, Cutaneous 2Vascular Malformations 1Uterine Cervical Dysplasia 1Pilonidal Sinus 1Pancreatic Neoplasms 1Mycosis Fungoides 1Keratosis, Actinic 1Hemangioma, Capillary 1Hemangioma 1Dermatitis, Contact 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Timolol 3Propranolol 3Solutions 2Prednisone 2Prednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Saline Solution 1Ointments 1Mupirocin 1Methylprednisolone 1Imiquimod 1Gels 1Everolimus 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hemangioma × Ointments × Clear all
NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡